These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8579798)

  • 1. Detection of psychoactive drugs using 19F MR spectroscopy.
    Bartels M; Albert K
    J Neural Transm Gen Sect; 1995; 99(1-3):1-6. PubMed ID: 8579798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 19F nuclear magnetic resonance spectroscopy of trifluorinated neuroleptics in the rat.
    Albert K; Rembold H; Kruppa G; Bayer E; Bartels M; Schmalzing G
    NMR Biomed; 1990 Jun; 3(3):120-3. PubMed ID: 2386658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F nuclear magnetic resonance spectroscopy of neuroleptics: the first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain.
    Bartels M; Günther U; Albert K; Mann K; Schuff N; Stuckstedte H
    Biol Psychiatry; 1991 Oct; 30(7):656-62. PubMed ID: 1958765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19F magnetic resonance imaging and spectroscopy of a fluorinated neuroleptic ligand: in vivo and in vitro studies.
    Arndt DC; Ratner AV; Faull KF; Barchas JD; Young SW
    Psychiatry Res; 1988 Jul; 25(1):73-9. PubMed ID: 3217469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study.
    Karson CN; Newton JE; Mohanakrishnan P; Sprigg J; Komoroski RA
    Psychiatry Res; 1992 Aug; 45(2):95-104. PubMed ID: 1362616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    Strauss WL; Layton ME; Hayes CE; Dager SR
    Am J Psychiatry; 1997 Apr; 154(4):516-22. PubMed ID: 9090339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated psychopharmacological agents: noninvasive observation by fluorine-19 nuclear magnetic resonance.
    Bartels M; Albert K; Kruppa G; Mann K; Schroth G; Tabarelli S; Zabel M
    Psychiatry Res; 1986 Jul; 18(3):197-201. PubMed ID: 3749381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19F NMR spectrometric determination of the partition coefficients of some fluorinated psychotropic drugs between phosphatidylcholine bilayer vesicles and water.
    Omran AA; Kitamura K; Takegami S; Kume M; Yoshida M; El-Sayed AA; Mohamed MH; Abdel-Mottaleb M
    J Pharm Biomed Anal; 2002 Nov; 30(4):1087-92. PubMed ID: 12408899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate.
    Sassa T; Suhara T; Ikehira H; Obata T; Girard F; Tanada S; Okubo Y
    Psychiatry Clin Neurosci; 2002 Dec; 56(6):637-42. PubMed ID: 12485307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo 19F nuclear magnetic resonance of a monofluorinated neuroleptic in the rat.
    Günther U; Albert K
    NMR Biomed; 1993; 6(1):27-31. PubMed ID: 8096148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human brain pharmacokinetics using a two-compartment model.
    Strauss WL; Layton ME; Dager SR
    Biol Psychiatry; 1999 May; 45(10):1384-8. PubMed ID: 10349045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-dimensional chemical shift imaging of fluorinated neuroleptics in rat brain in vivo by 19F NMR rotating frame zeugmatography.
    Nakada T; Kwee IL
    Magn Reson Imaging; 1989; 7(5):543-5. PubMed ID: 2575203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain.
    Komoroski RA; Newton JE; Cardwell D; Sprigg J; Pearce J; Karson CN
    Magn Reson Med; 1994 Feb; 31(2):204-11. PubMed ID: 8133756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy.
    Komoroski RA; Newton JE; Karson C; Cardwell D; Sprigg J
    Biol Psychiatry; 1991 Apr; 29(7):711-4. PubMed ID: 2054443
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy.
    Strauss WL; Layton ME; Dager SR
    Am J Psychiatry; 1998 Mar; 155(3):380-4. PubMed ID: 9501749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of psychoactive drugs in the human brain in vivo by MR spectroscopy.
    Komoroski RA
    AJNR Am J Neuroradiol; 1993; 14(5):1038-42. PubMed ID: 8237677
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.
    Durst P; Schuff N; Crocq MA; Mokrani MC; Macher JP
    Psychiatry Res; 1990 Dec; 35(2):107-14. PubMed ID: 2100803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy.
    Christensen JD; Yurgelun-Todd DA; Babb SM; Gruber SA; Cohen BM; Renshaw PF
    Brain Res; 1999 Jul; 834(1-2):1-5. PubMed ID: 10407087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-19 nuclear magnetic resonance imaging and spectroscopy of sevoflurane uptake, distribution, and elimination in rat brain.
    Xu Y; Tang P; Zhang W; Firestone L; Winter PM
    Anesthesiology; 1995 Oct; 83(4):766-74. PubMed ID: 7574056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
    Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
    NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.